Cisbio international, an established developer of HTRF(R) technology and services used in assay development and drug screening, announced new business collaborations with two of the life science industry’s leading reagent suppliers, Cell Signaling Technology, Inc. (CST) and Upstate. These latest partnerships with well-established reagent developers will allow Cisbio to extend its HTRF(R) technology into one of the largest fields within drug discovery: kinase screening. The announcement was made today at the Drug Discovery Technology conference in Boston, MA.
